Vasohibin-2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor-2 and growth/differentiation factor-15 expression
Authors:
Open Access
- 10 June 2014
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 10 (2) , 663-669
Abstract
Vasohibin‑2 (VASH2) is an angiogenic factor, and has been previously reported to be a cancer‑related gene, with cytoplasmic and karyotypic forms. In the current study VASH2 expression in human breast cancer tissue and adjacent non‑cancerous tissue was investigated with immunohistochemistry. MCF‑7 and BT474 human breast cancer cells were transfected with lentiviral constructs to generate in vitro VASH2 overexpression and knockdown models. In addition, BALB/cA nude mice were inoculated subcutaneously with transfected cells to generate in vivo models of VASH2 overexpression and knockdown. The effect of VASH2 on cell proliferation was investigated using a bromodeoxyuridine assay in vitro and immunohistochemistry of Ki67 in xenograft tumors. Growth factors were investigated using a human growth factor array, and certain factors were further confirmed by an immunoblot. The results indicated that the expression level of cytoplasmic VASH2 was higher in breast cancer tissues with a Ki67 (a proliferation marker) level of ≥14%, compared with tissues with a Ki67 level of <14%. VASH2 induced proliferation in vitro and in vivo. Four growth factors activated by VASH2 were identified as follows: Fibroblast growth factor 2 (FGF2), growth/differentiation factor‑15 (GDF15), insulin‑like growth factor‑binding protein (IGFBP)3 and IGFBP6. FGF2 and GDF15 may contribute to VASH2‑induced proliferation. The current study identified a novel role for VASH2 in human breast cancer, and this knowledge suggests that VASH2 may be a novel target in breast cancer treatment.Keywords
This publication has 24 references indexed in Scilit:
- Correlation between Ki67 and Breast Cancer PrognosisOncology, 2013
- The vasohibin family: a novel family for angiogenesis regulationThe Journal of Biochemistry, 2012
- Roles for Growth Factors in Cancer ProgressionPhysiology, 2010
- Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesisBlood, 2009
- Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor VasohibinArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breastEuropean Journal of Cancer, 1997
- Monoclonal antibodies Ki‐S3 and Ki‐S5 yield new data on the ‘Ki‐67’proteinsCell Proliferation, 1996
- Correlation of Insulin-Like Growth Factor-Binding Protein-3 Messenger RNA With Protein Expression in Primary Breast Cancer Tissues: Detection of Higher Levels in Tumors With Poor Prognostic FeaturesJNCI: Journal of the National Cancer Institute, 1996
- Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytesCytometry, 1991
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980